Wed, February 2, 2011
Tue, February 1, 2011
[ Tue, Feb 01st 2011 ] - Market Wire
Taleo to Acquire Cytiva
Mon, January 31, 2011
Sun, January 30, 2011
Fri, January 28, 2011
Thu, January 27, 2011
[ Thu, Jan 27th 2011 ] - Market Wire
Mortgage Rates a Mixed Bag
Wed, January 26, 2011
Tue, January 25, 2011
Mon, January 24, 2011
[ Mon, Jan 24th 2011 ] - Market Wire
00 pm ET
Fri, January 21, 2011
Thu, January 20, 2011
Wed, January 19, 2011
Tue, January 18, 2011
Mon, January 17, 2011
[ Mon, Jan 17th 2011 ] - Market Wire
COM DEV Wins Military Contract
Fri, January 14, 2011
[ Fri, Jan 14th 2011 ] - Market Wire
00 p.m. PST (5:00 p.m. EST)

Bio-Rad to Report Fourth-Quarter and Full-Year 2010 Financial Results Thursday, February 24, 2011


//science-technology.news-articles.net/content/2 .. financial-results-thursday-february-24-2011.html
Published in Science and Technology on Wednesday, January 26th 2011 at 16:10 GMT by Market Wire   Print publication without navigation


HERCULES, CA--(Marketwire - January 26, 2011) - Bio-Rad Laboratories, Inc. (NYSE: [ BIO ]) and (NYSE: [ BIO.B ]), a multinational manufacturer and distributor of life science research and clinical diagnostic products, will report financial results for the fourth quarter and full year 2010 on Thursday, February 24, 2011, after the close of the market. The company will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.

Interested parties may access the call by dialing 866-202-0886 (in the U.S.) or 617-213-8841 (international), access number 25027707.

A live webcast of the conference call may be accessed in the "Investor Relations" section of [ www.bio-rad.com ]. A replay of the call will be available at 888-286-8010 (in the U.S.) or 617-801-6888 (international), access number 51107717, for seven days following the call. The webcast of the call will be archived on the Bio-Rad site for on-demand replay for up to a year and may be accessed in the "Investor Relations" section of [ www.bio-rad.com ].

About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: [ BIO ]) and (NYSE: [ BIO.B ]) has remained at the center of scientific discovery for more than 50 years, manufacturing and distributing a broad range of products for the life science research and clinical diagnostics markets. The company is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 85,000 research and industry customers worldwide through its global network of operations. The company employs over 6,800 people globally and had revenues of nearly $1.8 billion in 2009. For more information, please visit [ www.bio-rad.com ].


Publication Contributing Sources